DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Appeal No. 7071 of 2026 filed by Dhanashree Deshpande

SEBI 1 hr ago·1 Oct 2026, 12:30 pm

Company SEBI

A legal petition has been filed in the Supreme Court, challenging the decision of the Competition Commission of India (CCI). The case, Appeal No. 7071 of 2026, was submitted by Dhanashree Deshpande. The core of the dispute involves the interpretation of specific regulations regarding anti-competitive practices.

This legal action is significant for the broader market as it tests the limits of current competition laws. A ruling in favor of the appellant could alter how companies are monitored and penalized for unfair trade behavior. Investors should monitor the court's proceedings, as a favorable outcome for the appellant could lead to stricter enforcement of regulations, while a dismissal would likely maintain the status quo.